Literature DB >> 20009957

A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series.

Matthew C Foote1, Bryan H Burmeister, Janine Thomas, B Mark Smithers.   

Abstract

Three patients with metastatic melanoma were treated with intralesional rose bengal followed by external beam radiotherapy. In all cases patients had an impressive response without significant increase in acute radiation reaction.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20009957     DOI： 10.1097/CMR.0b013e328331caa2

Source DB:  PubMed          Journal:  Melanoma Res        ISSN： 0960-8931            Impact factor:   3.599


  11 in total

1.  15th international congress of Parkinson's disease and movement disorders and inaugural melanoma and cutaneous malignancy meeting.

Authors:  Walter Alexander
Journal:  P T       Date:  2011-09

Review 2.  Regional therapies for locoregionally advanced and unresectable melanoma.

Authors:  Evan S Weitman; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2018-05-08       Impact factor: 5.150

3.  Fluorescein analogues inhibit SecA ATPase: the first sub-micromolar inhibitor of bacterial protein translocation.

Authors:  Ying-Ju Huang; Hongyun Wang; Fen-Biao Gao; Minyong Li; Hsiuchin Yang; Binghe Wang; Phang C Tai
Journal:  ChemMedChem       Date:  2012-02-22       Impact factor: 3.466

4.  Selective toxicity of rose bengal to ovarian cancer cells in vitro.

Authors:  Steven B Koevary
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-06-25

Review 5.  Developments in Intralesional Therapy for Metastatic Melanoma.

Authors:  Sarah Sloot; Omar M Rashid; Arnod A Sarnaik; Jonathan S Zager
Journal:  Cancer Control       Date:  2016-01       Impact factor: 3.302

Review 6.  The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.

Authors:  Emmanuel Gabriel; Joseph Skitzki
Journal:  Cancers (Basel)       Date:  2015-07-01       Impact factor: 6.639

7.  Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma.

Authors:  John F Thompson; Sanjiv S Agarwala; B Mark Smithers; Merrick I Ross; Charles R Scoggins; Brendon J Coventry; Susan J Neuhaus; David R Minor; Jamie M Singer; Eric A Wachter
Journal:  Ann Surg Oncol       Date:  2014-10-28       Impact factor: 5.344

8.  Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit.

Authors:  Mitchell H Giles; Brendon J Coventry
Journal:  Cancer Manag Res       Date:  2013-08-20       Impact factor: 3.989

9.  A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.

Authors:  Julian Biau; Flavien Devun; Wael Jdey; Ewa Kotula; Maria Quanz; Emmanuel Chautard; Mano Sayarath; Jian-Sheng Sun; Pierre Verrelle; Marie Dutreix
Journal:  Neoplasia       Date:  2014-10-23       Impact factor: 5.715

10.  Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer.

Authors:  Paul Toomey; Krithika Kodumudi; Amy Weber; Lisa Kuhn; Ellen Moore; Amod A Sarnaik; Shari Pilon-Thomas
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.